Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Inspire Medical Systems Inc.

In a report released today, Richard Newitter from Truist Financial maintained a Hold rating on Inspire Medical Systems, with a price target of $50....

Current Yield	N/A	Payout Ratio	0.00%
Annual DPS	$0.00	Growth Streak	0 years
Ex-Dividend	Invalid Date	Pay Date	Invalid Date
Record Date	N/A	Declaration	N/A
Frequency	NA	Quarterly Est	$0.00

	A	B	C	D
1	Symbol	Price	Change	Volume
2	INSP	$43.07	+2.01%	922.06K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	INSP	$43.07	+2.0%	922.06K
3
4
5
6

INSP

INSP

Dividend Overview

Get Inspire Medical Systems Inc. Data in Excel

Get Inspire Medical Systems Inc. Data in Excel